
G Square backs Pharmacy2U
G Square has led a £40m funding round for Pharmacy2U, a UK-based online pharmacy that provides a platform to order medication, and set up a repeat prescription.
Following the investment, which also saw the participation of current investor BGF, G Square will become Pharmacy2U's majority shareholder.
The firm's operating partner Ted Smith will join the company's board of directors as non-executive chair to support Pharmacy2U's growth and expansion.
The fresh capital will be used by the company to finance the growth of its online NHS repeat prescription service and to further invest in the development of its technology.
Previous funding
BGF provided two separate funding rounds to Pharmacy2U, the first in 2016 to support the merger between Pharmacy2U and ChemistDirect.co.uk. The second investment came 10 months later, in May 2017.
Company
Founded by a team of pharmacists in 1999, Pharmacy2U is an online pharmacy, providing 100,000 people in the UK with their NHS repeat prescriptions. Pharmacy2U also offers a private online doctor service with registered GPs and operates through its sister company ChemistDirect.co.uk, which specialises in a range of over-the-counter medicines and general healthcare products.
Pharmacy2U's repeat prescription service has seen its number of customers surge by 178% over the past 12 months, with 25,000 new patients registering in the last month alone, according to the company.
People
Pharmacy2U – Mark Livingstone (CEO).
G Square – Laurent Ganem (founder, CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater